Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Erectile Dysfunction
Interventions
DRUG

PF-00446687

Single 200mg dose as an oral solution

DRUG

Placebo

Placebo for oral solution

DRUG

Placebo

Placebo for tablet

DRUG

Sildenafil

Single oral dose 100 mg tablet

DRUG

PF-00446687

Single 125 mg dose as an oral solution

DRUG

PF-00446687

Single 175 mg dose as an oral solution

DRUG

PF-00446687

Single 20 mg dose as an oral solution

DRUG

Placebo

Placebo for oral solution

DRUG

Placebo

Placebo for tablet

DRUG

Sildenafil

Single oral dose 100 mg tablet

Trial Locations (3)

Unknown

Pfizer Investigational Site, Oslo

BT9 6AD

Pfizer Investigational Site, Belfast

LS2 9LH

Pfizer Investigational Site, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY